Health Condition 1: E538- Deficiency of other specified B group vitamins
Conditions
Interventions
Intervention1: T. Vitamin b12 (cyanocobalamin): 1000mcg PO daily for 90 days
Control Intervention1: Inj Vitamin B12: 1000mcg IM daily for 7 days - weekly for 6 weeks - monthly for 3months total
Sponsors
Intramural research fund committee JIPMER
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women 18 years and above between 14-28 weeks diagnosed with Vitamin B12 deficiency (Serum Vitamin B12 levels less than 200pg/ml)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of oral versus intramuscular vitamin b12 administration on its mean serum levels 3 months post treatment among pregnant women with mild to moderate Vitamin B12 deficiency in second trimester of pregnancyTimepoint: Comparison of serum Vitamin B12 between the two groups of intervention at 3 months post treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the changes in hematological parameters(hemoglobin, MCV, MCH, MCHC, peripheral smear, platelet count, total leukocyte counts) 3 months post treatment between the groups To compare the adverse effects between the two groupsTimepoint: Comparison of hematological parameters between the two groups of intervention at basline, 1 month, 2 month & 3 month post initiation of treatment | — |
Countries
India
Contacts
Public ContactDr. Ashwini Vishalakshi.L
Jawaharlal Institute of Postgraduate Medical Education and Research
Outcome results
None listed